Tuesday, March 17, 2026

Yuhan’s Leclaza and J&J’s Rybrevant: How This Cancer Combo Surged Past 1 Billion USD in Sales

Sales of Yuhan's lung cancer drug 'Lazertinib' and J&J's 'Amivantamab' exceeded 1 trillion won last year.

KG Mobility Reports 11.4% Global Sales Drop in March, Despite Export Growth

KG Mobility's global sales fell 11.4% in March, despite a 4.6% rise in exports, due to a 31.8% drop in South Korean sales.

YG Plus Shares Drop 11% After Rosé’s “APT.” Success Boosted Stock

YG Plus stock dropped 11% on Tuesday, following a surge from Rosé's "APT." Poor earnings and profit-taking contributed to the decline.

Tag: Dior

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.